Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies.
The purpose of this study was to explore the sequential imaging and histologic alterations of tumor blood vessels in the patient with solid malignancies after extracorporeal treatment of high-intensity focused ultrasound (HIFU). A total of 164 patients underwent extracorporeal HIFU ablation of malignant solid tumors. After HIFU treatment, enhanced magnetic resonance imaging (MRI), color Doppler ultrasound (US) imaging, dynamic radionuclide scanning, digital subtraction angiography, and histologic study were performed to monitor the response of tumor vessels to HIFU ablation. Compared with tumor images in the patients before HIFU, clinical images showed an abrupt interruption, followed by the cessation of blood flow within the tumor vessels after HIFU treatment. The histologic examination indicated that not only the treated tumor cells showed coagulative necrosis, but also small tumor vessels were severely damaged by the HIFU treatment. The results strongly imply that the damaged tumor vessels might play a critical role in secondary tumor cell death, and then indirectly strengthen the destructive force of focused US beams on tumor tissue. It is concluded that tumor vessel damage can be induced by HIFU, which may be a promising strategy in the treatment of patients with solid malignancies.
Wu
Feng
F
Clinical Center for Tumor Therapy of 2nd Affiliated Hospital, Institute of Ultrasonic Engineering in Medicine, Chongqing University of Medical Sciences, 1 Medical College Road, Chongqing 400 016, China. mfengwu@yahoo.com
Chen
Wen-Zhi
WZ
Bai
Jin
J
Zou
Jian-Zhong
JZ
Wang
Zhi-Long
ZL
Zhu
Hui
H
Wang
Zhi-Biao
ZB
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017115:Catheter Ablation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000098:blood supply* / Q000175:diagnosis / Q000628:therapy*; D014464:Ultrasonic Therapy / Q000379:methods*